Learning objectives
After attending this masterclass, participants should be able to:
• Identify the interactions and common pathways across immune-mediated
inflammatory diseases
• Evaluate treatment targets and outcome measures for psoriasis and psoriatic arthritis
• Describe factors that influence treatment selection and management of patients
with comorbidities
• Integrate the latest clinical safety and efficacy data and real-world data in the
management of psoriasis and psoriatic arthritis
• Hypothesize how treatment optimization strategies could be utilized for optimal
long-term patient outcomes